Molecular Formula | C19H24N8O10S3 |
Molar Mass | 620.64 |
Storage Condition | 2-8℃ |
In vitro study | Cefoselis concentration-dependently inhibited GABA-induced currents with an IC50 of 185 mM. Cefoselis had good anti-staphylococcal activity against strains of MSSA and was as active against multidrug-resistant enterobacteria as the other two compounds, Cefepime and Cefpirome. Cefoselis appeared dose-dependently in the extracellular fluid of the brain in proportion to its blood levels. Cefoselis, a novel parenteral cephalosporin active against Gram-positive and Gram-negative aerobic clinical strains. |
In vivo study | In normal rats, Cefoselis caused a large increase in extracellular glutamate concentration. Convulsions induced by Cefoselis (50 mg/animal) were modified by 5-methyl -10, 11-dihydro-5h-dibenzo [a,d] cycloheptene-5, 10-imine (MK-801), pretreatment with diazepam and phenobarbital prevented,(ED(50) values (mg/kg) of 0.78,1.59 and 33.0, respectively), but was not affected by carbamazepine or phenytoin. |
Reference Show more | 1. [IF=3.681] Dong Wei-chong et al."A Direct Injection Technique to Improve Biosafety to Analyze Levetiracetam Concentrations in Human Serum and Its Application in Therapeutic Drug Monitoring."Ther Drug Monit. 2021 Apr;43(2):292-297 |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 1.611 ml | 8.056 ml | 16.113 ml |
5 mM | 0.322 ml | 1.611 ml | 3.223 ml |
10 mM | 0.161 ml | 0.806 ml | 1.611 ml |
5 mM | 0.032 ml | 0.161 ml | 0.322 ml |